ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · IEX Real-Time Price · USD
0.0799
+0.0014 (1.78%)
At close: Jul 26, 2024, 4:00 PM
0.0789
-0.0010 (-1.25%)
After-hours: Jul 26, 2024, 7:57 PM EDT
ENDRA Life Sciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
5.61M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IM Cannabis | 53.73M |
| Biomerica | 5.41M |
| Innovative Eyewear | 1.39M |
| TFF Pharmaceuticals | 885.72K |
| Titan Pharmaceuticals | 87.00K |
| Oragenics | 20.63K |
| Ainos | -28.44K |
NDRA News
- 7 weeks ago - ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering - Business Wire
- 7 weeks ago - AM Best to Host Webinar on Engaging Defense Counsel Pre-Lawsuit - Business Wire
- 2 months ago - ENDRA Provides Update Following In-person Meeting with FDA - Business Wire
- 2 months ago - ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update - Business Wire
- 2 months ago - ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024 - Business Wire
- 3 months ago - ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents - Business Wire
- 4 months ago - ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - Business Wire
- 4 months ago - ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024 - Business Wire